Ralph B. Arlinghaus - Publications

The University of Texas Graduate School of Biomedical Sciences at Houston 
Cell Biology, Biostatistics Biology, Genetics, Oncology

214 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Chappell WH, Candido S, Abrams SL, Russo S, Ove R, Martelli AM, Cocco L, Ramazzotti G, Cervello M, Montalto G, Steelman LS, Leng X, Arlinghaus RB, Libra M, McCubrey JA. Roles of p53, NF-κB and the androgen receptor in controlling NGAL expression in prostate cancer cell lines. Advances in Biological Regulation. PMID 29861174 DOI: 10.1016/J.Jbior.2018.05.002  0.48
2017 Gomez-Chou S, Swidnicka-Siergiejko A, Badi N, Chavez-Tomar M, Lesinski GB, Bekaii-Saab T, Farren MR, Mace TA, Schmidt C, Liu Y, Deng D, Hwang RF, Zhou L, Moore TT, Chatterjee D, ... ... Arlinghaus RB, et al. Lipocalin-2 Promotes Pancreatic Ductal Adenocarcinoma by Regulating Inflammation in the Tumor Microenvironment. Cancer Research. PMID 28249896 DOI: 10.1158/0008-5472.Can-16-1986  0.48
2016 Chakraborty SN, Leng X, Perazzona B, Sun X, Lin YH, Arlinghaus RB. Combination of JAK2 and HSP90 inhibitors: an effective therapeutic option in drug-resistant chronic myelogenous leukemia. Genes & Cancer. 7: 201-8. PMID 27551334 DOI: 10.18632/Genesandcancer.111  0.48
2016 Mu C, Wu X, Ma H, Tao W, Zhang G, Xia X, Shen J, Mai J, Sun T, Sun X, Arlinghaus RB, Shen H. Effective concentration of a multi-kinase inhibitor within bone marrow correlates with in vitro cell killing in therapy-resistant chronic myeloid leukemia. Molecular Cancer Therapeutics. PMID 26846820 DOI: 10.1158/1535-7163.Mct-15-0577-T  0.68
2015 Tao W, Chakraborty SN, Leng X, Ma H, Arlinghaus RB. HSP90 inhibitor AUY922 induces cell death by disruption of the Bcr-Abl, Jak2 and HSP90 signaling network complex in leukemia cells. Genes & Cancer. 6: 19-29. PMID 25821558 DOI: 10.18632/Genesandcancer.49  0.68
2015 Mallampati S, Leng X, Ma H, Zeng J, Li J, Wang H, Lin K, Lu Y, Yang Y, Sun B, Gong Y, Lee JS, Konopleva M, Andreeff M, Arlinghaus RB, et al. Tyrosine kinase inhibitors induce mesenchymal stem cell-mediated resistance in BCR-ABL+ acute lymphoblastic leukemia. Blood. 125: 2968-73. PMID 25712988 DOI: 10.1182/Blood-2014-05-576421  0.68
2014 Ma H, Mallampati S, Lu Y, Sun B, Wang E, Leng X, Gong Y, Shen H, Yin CC, Jones D, Amin HM, You MJ, Zweidler-McKay P, Ma Y, Kantarjian HM, ... Arlinghaus RB, et al. The Sox4/Tcf7l1 axis promotes progression of BCR-ABL-positive acute lymphoblastic leukemia. Haematologica. 99: 1591-8. PMID 24997151 DOI: 10.3324/Haematol.2014.104695  0.48
2014 Tao W, Leng X, Chakraborty SN, Ma H, Arlinghaus RB. c-Abl activates janus kinase 2 in normal hematopoietic cells. The Journal of Biological Chemistry. 289: 21463-72. PMID 24923444 DOI: 10.1074/Jbc.M114.554501  0.68
2013 Neviani P, Harb JG, Oaks JJ, Santhanam R, Walker CJ, Ellis JJ, Ferenchak G, Dorrance AM, Paisie CA, Eiring AM, Ma Y, Mao HC, Zhang B, Wunderlich M, May PC, ... ... Arlinghaus RB, et al. PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells. The Journal of Clinical Investigation. 123: 4144-57. PMID 23999433 DOI: 10.1172/Jci68951  0.68
2013 Oaks JJ, Santhanam R, Walker CJ, Roof S, Harb JG, Ferenchak G, Eisfeld AK, Van Brocklyn JR, Briesewitz R, Saddoughi SA, Nagata K, Bittman R, Caligiuri MA, Abdel-Wahab O, Levine R, ... Arlinghaus RB, et al. Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies. Blood. 122: 1923-34. PMID 23926298 DOI: 10.1182/Blood-2013-03-492181  0.68
2013 Chakraborty S, Lin YH, Leng X, Miranda RN, Medeiros LJ, Shpall E, Arlinghaus RB. Activation of Jak2 in patients with blast crisis chronic myelogenous leukemia: Inhibition of Jak2 inactivates Lyn kinase Blood Cancer Journal. 3. DOI: 10.1038/bcj.2013.41  0.68
2012 Song Y, Zhang Y, Bernard PE, Reuben JM, Ueno NT, Arlinghaus RB, Zu Y, Qin L. Multiplexed volumetric bar-chart chip for point-of-care diagnostics. Nature Communications. 3: 1283. PMID 23250413 DOI: 10.1038/Ncomms2292  0.68
2012 Katayama H, Wang J, Treekitkarnmongkol W, Kawai H, Sasai K, Zhang H, Wang H, Adams HP, Jiang S, Chakraborty SN, Suzuki F, Arlinghaus RB, Liu J, Mobley JA, Grizzle WE, et al. Aurora kinase-A inactivates DNA damage-induced apoptosis and spindle assembly checkpoint response functions of p73. Cancer Cell. 21: 196-211. PMID 22340593 DOI: 10.1016/J.Ccr.2011.12.025  0.68
2012 Singh MM, Irwin ME, Gao Y, Ban K, Shi P, Arlinghaus RB, Amin HM, Chandra J. Inhibition of the NADPH oxidase regulates heme oxygenase 1 expression in chronic myeloid leukemia. Cancer. 118: 3433-45. PMID 22139798 DOI: 10.1002/Cncr.26621  0.68
2012 Zhang H, Lu W, Liu T, Chen G, Chen Z, Trachootham D, Arlinghaus RB, Huang P. Abstract 2007: Differential roles of BCL-XL and BCL-2 in protecting mitochondria against oxidative stress in CML cells Cancer Research. 72: 2007-2007. DOI: 10.1158/1538-7445.Am2012-2007  0.44
2011 Corrado C, Raimondo S, Flugy AM, Fontana S, Santoro A, Stassi G, Marfia A, Iovino F, Arlinghaus R, Kohn EC, Leo GD, Alessandro R. Carboxyamidotriazole inhibits cell growth of imatinib-resistant chronic myeloid leukaemia cells including T315I Bcr-Abl mutant by a redox-mediated mechanism. Cancer Letters. 300: 205-14. PMID 21041018 DOI: 10.1016/J.Canlet.2010.10.007  0.68
2011 Leng X, Wu Y, Arlinghaus RB. Relationships of lipocalin 2 with breast tumorigenesis and metastasis. Journal of Cellular Physiology. 226: 309-14. PMID 20857428 DOI: 10.1002/jcp.22403  0.68
2010 Samanta AK, Chakraborty SN, Wang Y, Schlette E, Reddy EP, Arlinghaus RB. Destabilization of Bcr-Abl/Jak2 Network by a Jak2/Abl Kinase Inhibitor ON044580 Overcomes Drug Resistance in Blast Crisis Chronic Myelogenous Leukemia (CML). Genes & Cancer. 1: 346-59. PMID 20798787 DOI: 10.1177/1947601910372232  0.68
2010 Jatiani SS, Cosenza SC, Reddy MV, Ha JH, Baker SJ, Samanta AK, Olnes MJ, Pfannes L, Sloand EM, Arlinghaus RB, Reddy EP. A Non-ATP-Competitive Dual Inhibitor of JAK2 and BCR-ABL Kinases: Elucidation of a Novel Therapeutic Spectrum Based on Substrate Competitive Inhibition. Genes & Cancer. 1: 331-45. PMID 20717479 DOI: 10.1177/1947601910371337  0.68
2010 Shi P, Chandra J, Sun X, Gergely M, Cortes JE, Garcia-Manero G, Arlinghaus RB, Lai R, Amin HM. Inhibition of IGF-IR tyrosine kinase induces apoptosis and cell cycle arrest in imatinib-resistant chronic myeloid leukaemia cells. Journal of Cellular and Molecular Medicine. 14: 1777-92. PMID 19508387 DOI: 10.1111/J.1582-4934.2009.00795.X  0.68
2009 Leng X, Ding T, Lin H, Wang Y, Wu Y, Arlinghaus RB. WITHDRAWN: Requirement of lipocalin 2 in breast cancer. Advances in Enzyme Regulation. PMID 19914274 DOI: 10.1016/J.Advenzreg.2009.10.001  0.48
2009 Leng X, Ding T, Lin H, Wang Y, Hu L, Hu J, Feig B, Zhang W, Pusztai L, Symmans WF, Wu Y, Arlinghaus RB. Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis. Cancer Research. 69: 8579-84. PMID 19887608 DOI: 10.1158/0008-5472.Can-09-1934  0.68
2009 Leng X, Ding T, Arlinghaus R. Requirement of lipocalin 2 for hematopoietic and solid tumor malignancies. Advances in Enzyme Regulation. 49: 142-6. PMID 19344630 DOI: 10.1016/J.Advenzreg.2009.01.010  0.68
2009 Samanta AK, Chakraborty SN, Wang Y, Kantarjian H, Sun X, Hood J, Perrotti D, Arlinghaus RB. Jak2 inhibition deactivates Lyn kinase through the SET-PP2A-SHP1 pathway, causing apoptosis in drug-resistant cells from chronic myelogenous leukemia patients Oncogene. 28: 1669-1681. PMID 19234487 DOI: 10.1038/Onc.2009.7  0.68
2009 Muehlberg FL, Song YH, Krohn A, Pinilla SP, Droll LH, Leng X, Seidensticker M, Ricke J, Altman AM, Devarajan E, Liu W, Arlinghaus RB, Alt EU. Tissue-resident stem cells promote breast cancer growth and metastasis. Carcinogenesis. 30: 589-97. PMID 19181699 DOI: 10.1093/Carcin/Bgp036  0.68
2008 Arlinghaus R, Leng X. Requirement of lipocalin 2 for chronic myeloid leukemia Leukemia and Lymphoma. 49: 600-603. PMID 18398717 DOI: 10.1080/10428190701859664  0.68
2008 Zhang H, Trachootham D, Lu W, Carew J, Giles FJ, Keating MJ, Arlinghaus RB, Huang P. Effective killing of Gleevec-resistant CML cells with T315I mutation by a natural compound PEITC through redox-mediated mechanism Leukemia. 22: 1191-1199. PMID 18385754 DOI: 10.1038/Leu.2008.74  0.68
2008 Ban K, Gao Y, Amin HM, Howard A, Miller C, Lin Q, Leng X, Munsell M, Bar-Eli M, Arlinghaus RB, Chandra J. BCR-ABL1 mediates up-regulation of Fyn in chronic myelogenous leukemia. Blood. 111: 2904-8. PMID 18180382 DOI: 10.1182/Blood-2007-05-091769  0.68
2007 Tari AM, Gutiérrez-Puente Y, Monaco G, Stephens C, Sun T, Rosenblum M, Belmont J, Arlinghaus R, Lopez-Berestein G. Liposome-incorporated Grb2 antisense oligodeoxynucleotide increases the survival of mice bearing bcr-abl-positive leukemia xenografts. International Journal of Oncology. 31: 1243-1250. DOI: 10.3892/Ijo.31.5.1243  0.44
2006 Trachootham D, Zhou Y, Zhang H, Demizu Y, Chen Z, Pelicano H, Chiao PJ, Achanta G, Arlinghaus RB, Liu J, Huang P. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell. 10: 241-52. PMID 16959615 DOI: 10.1016/J.Ccr.2006.08.009  0.68
2006 Samanta AK, Lin H, Sun T, Kantarjian H, Arlinghaus RB. Janus kinase 2: a critical target in chronic myelogenous leukemia. Cancer Research. 66: 6468-72. PMID 16818614 DOI: 10.1158/0008-5472.Can-06-0025  0.68
2006 Ling X, Wang Y, Dietrich MF, Andreeff M, Arlinghaus RB. Vaccination with leukemia cells expressing cell-surface-associated GM-CSF blocks leukemia induction in immunocompetent mice Oncogene. 25: 4483-4490. PMID 16547503 DOI: 10.1038/Sj.Onc.1209477  0.68
2005 Verstovsek S, Golemovic M, Kantarjian H, Manshouri T, Estrov Z, Manley P, Sun T, Arlinghaus RB, Alland L, Dugan M, Cortes J, Giles F, Beran M. AMN107, a novel aminopyrimidine inhibitor of p190 Bcr-Abl activation and of in vitro proliferation of Philadelphia-positive acute lymphoblastic leukemia cells. Cancer. 104: 1230-6. PMID 16078266 DOI: 10.1002/cncr.21299  0.68
2005 Golemovic M, Verstovsek S, Giles F, Cortes J, Manshouri T, Manley PW, Mestan J, Dugan M, Alland L, Griffin JD, Arlinghaus RB, Sun T, Kantarjian H, Beran M. AMN107, a novel aminopyrimidine inhibitor of Bcr-Abl, has in vitro activity against imatinib-resistant chronic myeloid leukemia. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 4941-7. PMID 16000593 DOI: 10.1158/1078-0432.Ccr-04-2601  0.68
2005 Ling X, Arlinghaus RB. Knockdown of STAT3 expression by RNA interference inhibits the induction of breast tumors in immunocompetent mice. Cancer Research. 65: 2532-6. PMID 15805244 DOI: 10.1158/0008-5472.CAN-04-2425  0.68
2005 Lin H, Monaco G, Sun T, Ling X, Stephens C, Xie S, Belmont J, Arlinghaus R. Bcr-Abl-mediated suppression of normal hematopoiesis in leukemia. Oncogene. 24: 3246-56. PMID 15735695 DOI: 10.1038/Sj.Onc.1208500  0.44
2004 Sun T, Arlinghaus RB. Preparation and application of polyclonal and monoclonal sequence-specific anti-phosphoamino acid antibodies. Current Protocols in Protein Science / Editorial Board, John E. Coligan ... [Et Al.]. Unit 13.6. PMID 18429250 DOI: 10.1002/0471140864.Ps1306S34  0.68
2004 Arlinghaus R, Sun T. Signal transduction pathways in Bcr-Abl transformed cells Cancer Treatment and Research. 119: 239-270. PMID 15164881 DOI: 10.1007/1-4020-7847-1_12  0.68
2004 Donato NJ, Wu JY, Stapley J, Lin H, Arlinghaus R, Aggarwal BB, Shishodia S, Albitar M, Hayes K, Kantarjian H, Talpaz M, Shishodin S. Imatinib mesylate resistance through BCR-ABL independence in chronic myelogenous leukemia. Cancer Research. 64: 672-7. PMID 14744784 DOI: 10.1158/0008-5472.Can-03-1484  0.36
2004 Katayama H, Sasai K, Kawai H, Yuan ZM, Bondaruk J, Suzuki F, Fujii S, Arlinghaus RB, Czerniak BA, Sen S. Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. Nature Genetics. 36: 55-62. PMID 14702041 DOI: 10.1038/Ng1279  0.68
2003 Wang L, Duke L, Zhang PS, Arlinghaus RB, Symmans WF, Sahin A, Mendez R, Dai JL. Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer. Cancer Research. 63: 4724-30. PMID 12907655  0.68
2003 Mahon GM, Wang Y, Korus M, Kostenko E, Cheng L, Sun T, Arlinghaus RB, Whitehead IP. The c-Myc Oncoprotein Interacts with Bcr. Current Biology : Cb. 13: 437-41. PMID 12620195 DOI: 10.1016/S0960-9822(03)00090-3  0.68
2003 Ling X, Ma G, Sun T, Liu J, Arlinghaus RB. Bcr and Abl interaction: oncogenic activation of c-Abl by sequestering Bcr. Cancer Research. 63: 298-303. PMID 12543778  0.68
2003 Donato NJ, Wu JY, Stapley J, Gallick G, Lin H, Arlinghaus R, Talpaz M. BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571. Blood. 101: 690-8. PMID 12509383 DOI: 10.1182/Blood.V101.2.690  0.36
2003 Arlinghaus R, Lin H, Guo JQ, Kim H, Ke S. Reply to Rawer et al (second letter) Leukemia. 17: 2530-2530. DOI: 10.1038/Sj.Leu.2403194  0.36
2003 Arlinghaus R, Lin H, Kim H, Guo JQ. Response to Influence of stochastics on quantitative PCR in the detection of minimal residual disease by Rawer et al Leukemia. 17: 2528-2529. DOI: 10.1038/Sj.Leu.2403192  0.36
2002 Arlinghaus RB. Bcr: a negative regulator of the Bcr-Abl oncoprotein in leukemia. Oncogene. 21: 8560-7. PMID 12476302 DOI: 10.1038/Sj.Onc.1206083  0.68
2002 Guo JQ, Lin H, Kantarjian H, Talpaz M, Champlin R, Andreeff M, Glassman A, Arlinghaus RB. Comparison of competitive-nested PCR and real-time PCR in detecting BCR-ABL fusion transcripts in chronic myeloid leukemia patients Leukemia. 16: 2447-2453. PMID 12454751 DOI: 10.1038/Sj.Leu.2402730  0.68
2002 Xie S, Lin H, Sun T, Arlinghaus RB. Jak2 is involved in c-Myc induction by Bcr-Abl. Oncogene. 21: 7137-46. PMID 12370803 DOI: 10.1038/Sj.Onc.1205942  0.68
2002 Tan M, Jing T, Lan KH, Neal CL, Li P, Lee S, Fang D, Nagata Y, Liu J, Arlinghaus R, Hung MC, Yu D. Phosphorylation on tyrosine-15 of p34(Cdc2) by ErbB2 inhibits p34(Cdc2) activation and is involved in resistance to taxol-induced apoptosis. Molecular Cell. 9: 993-1004. PMID 12049736 DOI: 10.1016/S1097-2765(02)00510-5  0.68
2002 Verstovsek S, Lin H, Kantarjian H, Saglio G, De Micheli D, Pane F, Garcia-Manero G, Intrieri M, Rotoli B, Salvatore F, Guo JQ, Talpaz M, Specchia G, Pizzolo G, Liberati AM, ... ... Arlinghaus RB, et al. Neutrophilic-chronic myeloid leukemia: low levels of p230 BCR/ABL mRNA and undetectable BCR/ABL protein may predict an indolent course. Cancer. 94: 2416-25. PMID 12015767 DOI: 10.1002/Cncr.10490  0.68
2002 Lin H, Guo JQ, Andreeff M, Arlinghaus RB. Detection of dual TEL-ABL transcripts and a Tel-Abl protein containing phosphotyrosine in a chronic myeloid leukemia patient [1] Leukemia. 16: 294-297. PMID 11840298 DOI: 10.1038/Sj.Leu.2402353  0.68
2002 Hawk N, Sun T, Xie S, Wang Y, Wu Y, Liu J, Arlinghaus RB. Inhibition of the Bcr-Abl oncoprotein by Bcr requires phosphoserine 354. Cancer Research. 62: 386-90. PMID 11809685  0.68
2001 Nehete PN, Chitta S, Hossain MM, Hill L, Bernacky BJ, Baze W, Arlinghaus RB, Sastry KJ. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model. Vaccine. 20: 813-25. PMID 11738745 DOI: 10.1016/S0264-410X(01)00408-X  0.68
2001 Xie S, Wang Y, Liu J, Sun T, Wilson MB, Smithgall TE, Arlinghaus RB. Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation. Oncogene. 20: 6188-95. PMID 11593427 DOI: 10.1038/Sj.Onc.1204834  0.68
2001 Kardinal C, Konkol B, Lin H, Eulitz M, Schmidt EK, Estrov Z, Talpaz M, Arlinghaus RB, Feller SM. Chronic myelogenous leukemia blast cell proliferation is inhibited by peptides that disrupt Grb2-SoS complexes. Blood. 98: 1773-81. PMID 11535511 DOI: 10.1182/blood.V98.6.1773  0.68
2001 Sun T, Campbell M, Gordon W, Arlinghaus RB. Preparation and application of antibodies to phosphoamino acid sequences Biopolymers - Peptide Science Section. 60: 61-75. PMID 11376433 DOI: 10.1002/1097-0282(2001)60:1<61::Aid-Bip1004>3.0.Co;2-4  0.68
2001 Lin F, Monaco G, Sun T, Liu J, Lin H, Stephens C, Belmont J, Arlinghaus RB. BCR gene expression blocks Bcr-Abl induced pathogenicity in a mouse model Oncogene. 20: 1873-1881. PMID 11313935 DOI: 10.1038/Sj.Onc.1204409  0.68
2001 Pachmann K, Zhao S, Schenk T, Kantarjian H, El-Naggar AK, Siciliano MJ, Guo JQ, Arlinghaus RB, Andreeff M. Expression of bcr-abl mRNA in individual chronic myelogenous leukaemia cells as determined by in situ amplification. British Journal of Haematology. 112: 749-59. PMID 11260080 DOI: 10.1111/J.1365-2141.2001.02510.X  0.68
2001 Wang Y, Liu J, Wu Y, Luo W, Lin SH, Lin H, Hawk N, Sun T, Guo JQ, Estrov Z, Talpaz M, Champlin R, Arlinghaus RB. Expression of a truncated first exon BCR sequence in chronic myelogenous leukemia cells blocks cell growth and induces cell death Cancer Research. 61: 138-144. PMID 11196151  0.68
2000 Kardinal C, Konkol B, Schulz A, Posern G, Lin H, Adermann K, Eulitz M, Estrov Z, Talpaz M, Arlinghaus RB, Feller SM. Cell-penetrating SH3 domain blocker peptides inhibit proliferation of primary blast cells from CML patients Faseb Journal. 14: 1529-1538. PMID 10928987  0.68
2000 Lin H, Guo J, Andreff M, Arlinghaus RB. Dual tel-abl fusion in a PH-negative chronic myeloid leukemia patient Blood. 96.  0.68
2000 Xie S, Liu J, Sun T, Arlinghaus RB. Evidence that BCR-ABL activates JAK2 by direct tyrosine phosphorylation, and JAK2 activation by BCR-ABL is involved in blocking apoptosis Blood. 96.  0.68
1999 Le XF, Groner Y, Kornblau SM, Gu Y, Hittelman WN, Levanon D, Mehta K, Arlinghaus RB, Chang KS. Regulation of AML2/CBFA3 in hematopoietic cells through the retinoic acid receptor α-dependent signaling pathway Journal of Biological Chemistry. 274: 21651-21658. PMID 10419474 DOI: 10.1074/Jbc.274.31.21651  0.68
1999 Chen G, Yuan SS, Liu W, Xu Y, Trujillo K, Song B, Cong F, Goff SP, Wu Y, Arlinghaus R, Baltimore D, Gasser PJ, Park MS, Sung P, Lee EY. Radiation-induced assembly of Rad51 and Rad52 recombination complex requires ATM and c-Abl. The Journal of Biological Chemistry. 274: 12748-52. PMID 10212258 DOI: 10.1074/Jbc.274.18.12748  0.68
1998 Arlinghaus RB. The involvement of Bcr in leukemias with the Philadelphia chromosome Critical Reviews in Oncogenesis. 9: 1-18. PMID 9754444 DOI: 10.1615/Critrevoncog.V9.I1.10  0.68
1998 Beran M, Cao X, Estrov Z, Jeha S, Jin G, O'Brien S, Talpaz M, Arlinghaus RB, Lydon NB, Kantarjian H. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing M(r) 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148) Clinical Cancer Research. 4: 1661-1672. PMID 9676840  0.68
1998 Yang Y, Pham CD, Vuyyuru VB, Liu H, Arlinghaus RB, Singh B. Evidence of a functional interaction between serine 3 and serine 25 Mos phosphorylation sites: A dominant inhibitory role of serine 25 phosphorylation on mos protein kinase Journal of Biological Chemistry. 273: 15946-15953. PMID 9632642 DOI: 10.1074/Jbc.273.26.15946  0.68
1998 Schenk TM, Keyhani A, Bottcher S, Kliche KO, Goodacre A, Guo JQ, Arlinghaus RB, Kantarjian HM, Andreeff M. Multilineage involvement of Philadelphia chromosome positive acute lymphoblastic leukemia. Leukemia. 12: 666-74. PMID 9593263 DOI: 10.1038/Sj.Leu.2400986  0.68
1998 Yang Y, Pham CD, Arlinghaus RB, Khillan JS, Singh B. Elevated level of cyclin D1 in mos-transformed cells International Journal of Oncology. 12: 1199-1202. PMID 9538150 DOI: 10.3892/Ijo.12.5.1199  0.68
1998 Oka T, Sastry KJ, Nehete P, Schapiro SJ, Guo JQ, Talpaz M, Arlinghaus RB. Evidence for specific immune response against P210 BCR-ABL in long-term remission CML patients treated with interferon Leukemia. 12: 155-163. PMID 9519777 DOI: 10.1038/Sj.Leu.2400919  0.68
1998 Wu Y, Liu J, Arlinghaus RB. Requirement of two specific tyrosine residues for the catalytic activity of Bcr serine/threonine kinase Oncogene. 16: 141-146. PMID 9467953 DOI: 10.1038/Sj.Onc.1201524  0.68
1997 Singh B, Arlinghaus RB. Mos and the cell cycle Progress in Cell Cycle Research. 3: 251-259. PMID 9552420 DOI: 10.1007/978-1-4615-5371-7_20  0.68
1997 Wilson-Rawls J, Liu J, Laneuville P, Arlinghaus RB. P210 Bcr-Abl interacts with the interleukin-3 β(c) subunit and constitutively activates Jak2 Leukemia. 11: 428-431. PMID 9209414  0.68
1997 Ma G, Lu D, Wu Y, Liu J, Arlinghaus RB. Bcr phosphorylated on tyrosine 177 binds Grb2 Oncogene. 14: 2367-2372. PMID 9178913 DOI: 10.1038/Sj.Onc.1201053  0.68
1997 Tsui LV, Ramagli LS, Gao C, Pham CD, Pandita TK, Arlinghaus RB, Singh B. The biological effects of antisense mos expression in fibroblasts International Journal of Oncology. 11: 1171-1178. DOI: 10.3892/Ijo.11.6.1171  0.68
1997 Pham CD, Rungta M, Chandler DS, Yang Y, Arlinghaus RB, Rajagopalan S, Schwartz MR, Singh B. Essential role of c-mos in eggs: Reduced fertility and ovarian neoplasm in antisense mos transgenic mice International Journal of Gynecological Cancer. 7: 314-317. DOI: 10.1046/J.1525-1438.1997.00461.X  0.68
1996 Liu J, Wu Y, Arlinghaus RB. Sequences within the first exon of BCR inhibit the activated tyrosine kinases of c-Abl and the Bcr-Abl oncoprotein Cancer Research. 56: 5120-5124. PMID 8912843  0.68
1996 Casement KS, Arlinghaus RB, Sastry KJ. Cytotoxic T-lymphocyte response induced by a V3 loop synthetic peptide from an African HIV-1 isolate is cross-reactive against HIV-1 strains from North America/Europe region [7] Aids. 10: 1440-1441. PMID 8902081  0.68
1996 Guo JQ, Lian J, Glassman A, Talpaz M, Kantarjian H, Deisseroth AB, Arlinghaus RB. Comparison of bcr-abl protein expression and Philadelphia chromosome analyses in chronic myelogenous leukemia patients American Journal of Clinical Pathology. 106: 442-448. PMID 8853030 DOI: 10.1093/Ajcp/106.4.442  0.68
1996 Hochhaus A, Reiter A, Skladny H, Melo JV, Sick C, Berger U, Guo JQ, Arlinghaus RB, Hehlmann R, Goldman JM, Cross NCP. A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia Blood. 88: 2236-2240. PMID 8822944  0.68
1996 Wilson-Rawls J, Xie S, Liu J, Laneuville P, Arlinghaus RB. P210 Bcr-Abl interacts with the interleukin 3 receptor beta(c) subunit and constitutively induces its tyrosine phosphorylation. Cancer Research. 56: 3426-30. PMID 8758906  0.68
1996 Butturini A, Arlinghaus RB, Gale RP. BCR/ABL and leukemia Leukemia Research. 20: 523-529. PMID 8709625 DOI: 10.1016/0145-2126(95)00057-7  0.68
1996 Nehete PN, Johnson PC, Schapiro SJ, Arlinghaus RB, Sastry KJ. Cross-reactive T-cell proliferative responses to V3 peptides corresponding to different geographical HIV-1 isolates in HIV-seropositive individuals. Journal of Clinical Immunology. 16: 115-24. PMID 8690775 DOI: 10.1007/Bf01540958  0.68
1996 Gao C, Arlinghaus RB, Singh B. Further characterization of the c-mos transcript and its cell cycle specific expression in NIH3T3 cells Oncogene. 12: 1571-1576. PMID 8622874  0.68
1996 Liu J, Wu Y, Ma GZ, Lu D, Haataja L, Heisterkamp N, Groffen J, Arlinghaus RB. Inhibition of Bcr serine kinase by tyrosine phosphorylation Molecular and Cellular Biology. 16: 998-1005. PMID 8622703 DOI: 10.1128/Mcb.16.3.998  0.68
1996 Yang Y, Herrmann CH, Arlinghaus RB, Singh B. Inhibition of v-Mos kinase activity by protein kinase A Molecular and Cellular Biology. 16: 800-809. PMID 8622681 DOI: 10.1128/Mcb.16.3.800  0.68
1995 Sarkar AK, Tortolero-Luna G, Nehete PN, Arlinghaus RB, Mitchell MF, Sastry KJ. Studies on in vivo induction of cytotoxic T lymphocyte responses by synthetic peptides from E6 and E7 oncoproteins of human papillomavirus type 16 Viral Immunology. 8: 165-174. PMID 8833270  0.68
1995 Meyer MK, Nash MA, Arlinghaus RB. Identification of a new viral protein containing CAp30 and NCp10 sequences in murine and feline leukemia retroviruses. Journal of Virology. 69: 1353-8. PMID 7815521  0.68
1995 Pham CD, Arlinghaus RB, Zheng CF, Guan KL, Singh B. Characterization of MEK1 phosphorylation by the v-Mos protein Oncogene. 10: 1683-1688. PMID 7731726  0.68
1995 Nehete PN, Casement KS, Arlinghaus RB, Sastry KJ. Studies on in vivo induction of HIV-1 envelope-specific cytotoxic T lymphocytes by synthetic peptides from the V3 loop region of HIV-1 IIIB gp120 Cellular Immunology. 160: 217-223. PMID 7720083 DOI: 10.1016/0008-8749(95)80031-D  0.68
1995 Nehete PN, Murthy KK, Satterfield WC, Arlinghaus RB, Sastry KJ. Studies on V3-specific cross-reactive T-cell responses in chimpanzees chronically infected with HIV-1IIIB Aids. 9: 567-572. PMID 7662194 DOI: 10.1097/00002030-199506000-00006  0.68
1995 Casement KS, Nehete PN, Arlinghaus RB, Sastry KJ. Cross-Reactive Cytotoxic T Lymphocytes Induced by V3 Loop Synthetic Peptides from Different Strains of Human Immunodeficiency Virus Type 1 Virology. 211: 261-267. PMID 7645219 DOI: 10.1006/Viro.1995.1399  0.68
1994 Guo JQ, Lian JY, Xian YM, Lee MS, Deisseroth AB, Stass SA, Champlin RE, Talpaz M, Wang JYJ, Arlinghaus RB. BCR-ABL protein expression in peripheral blood cells of chronic myelogenous leukemia patients undergoing therapy Blood. 83: 3629-3637. PMID 8204887 DOI: 10.1182/Blood.V83.12.3629.3629  0.68
1994 Jagannadha Sastry K, Bender BS, Bell W, Small PA, Arlinghaus RB. Effects of influenza virus-specific cytotoxic T-lymphocyte responses induced by a synthetic nucleoprotein peptide on the survival of mice challenged with a lethal dose of virus Vaccine. 12: 1281-1287. PMID 7856292 DOI: 10.1016/S0264-410X(94)80053-3  0.68
1994 Nehete PN, Arlinghaus RB, Sastry KJ. Use of helper T cell-inducing peptides from conserved regions in HIV-1 env in a noncovalent mixture with a CTL-inducing V3-loop peptide for in vivo induction of long-lasting systemic CTL response Viral Immunology. 7: 189-197. PMID 7576033  0.68
1994 Ten Hoeve J, Arlinghaus RB, Guo JQ, Heisterkamp N, Groffen J. Tyrosine phosphorylation of CRKL in Philadelphia+ leukemia Blood. 84: 1731-1736. PMID 7521685 DOI: 10.1182/Blood.V84.6.1731.Bloodjournal8461731  0.68
1993 Nehete PN, Satterfield WC, Matherne CM, Arlinghaus RB, Sastry KJ. Induction of human immunodeficiency virus-specific T cell responses in rhesus monkeys by synthetic peptides from gp160 Aids Research and Human Retroviruses. 9: 235-240. PMID 8471313 DOI: 10.1089/Aid.1993.9.235  0.68
1993 Nash MA, Meyer MK, Decker GL, Arlinghaus RB. A subset of Pr65gag is nucleus associated in murine leukemia virus-infected cells. Journal of Virology. 67: 1350-6. PMID 8437220  0.68
1993 Liu J, Campbell M, Guo JQ, Lu D, Xian YM, Andersson BS, Arlinghaus RB. BCR-ABL tyrosine kinase is autophosphorylated or transphosphorylates p160 BCR on tyrosine predominantly within the first BCR exon Oncogene. 8: 101-109. PMID 8423987  0.68
1993 Campbell ML, Lu D, Guo JQ, Arlinghaus RB. Inhibition of phosphorylation of p160 BCR within p210 BCR-ABL complexes during early stages of phorbol ester-induced differentiation of K562 cells Cell Growth &Amp; Differentiation : the Molecular Biology Journal of the American Association For Cancer Research. 4: 581-588. PMID 8398898  0.68
1993 Guo JQ, Hirsch-Ginsberg CF, Xian YM, Stass SA, Champlin RE, Giralt SA, McCredie KB, Campbell ML, Arlinghaus RB. Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia Hematologic Pathology. 7: 91-106. PMID 8340287  0.68
1993 Bai W, Arlinghaus RB, Singh B. Association of v-Mos with soluble vimentin in vitro and in transformed cells Oncogene. 8: 2207-2212. PMID 8336943  0.68
1993 Skorski T, Kanakaraj P, Nieborowska-Skorska M, Ratajczak M, Szczylik C, Zon G, Arlinghaus RB, Gewirtz A, Perussia B, Calabretta B. p120 GAP requirement in normal and malignant human hematopoiesis Journal of Experimental Medicine. 178: 1923-1933. PMID 8245773 DOI: 10.1084/Jem.178.6.1923  0.68
1993 Nehete PN, Arlinghaus RB, Sastry KJ. Inhibition of human immunodeficiency virus type 1 infection and syncytium formation in human cells by V3 loop synthetic peptides from gp120 Journal of Virology. 67: 6841-6846. PMID 7692087 DOI: 10.1128/Jvi.67.11.6841-6846.1993  0.68
1993 Lu D, Liu J, Campbell M, Guo JQ, Heisterkamp N, Groffen J, Canaani E, Arlinghaus R. Tyrosine phosphorylation of P160 BCR by P210 BCR-ABL Blood. 82: 1257-1263. DOI: 10.1182/Blood.V82.4.1257.Bloodjournal8241257  0.44
1993 Tsui LV, Ramagli LS, Singh B, Nash M, Arlinghaus RB. Somatic cell expression of the mos proto-oncogene is cell cycle regulated: Highest RNA expression in the G2 phase International Journal of Oncology. 2: 493-502.  0.68
1992 Arlinghaus RB. Multiple BCR-related gene products and their proposed involvement in ligand-induced signal transduction pathways Molecular Carcinogenesis. 5: 171-173. PMID 1586447 DOI: 10.1002/Mc.2940050302  0.68
1992 Bai W, Singh B, Yang Y, Ramagli LS, Nash M, Herzog NK, Arlinghaus RB. The physical interactions between p37env-mos and tubulin structures Oncogene. 7: 493-500. PMID 1532247  0.68
1992 Sastry JK, Nehete PN, Khan S, Nowak BJ, Plunkett W, Arlinghaus RB, Farquhar D. Membrane-permeable dideoxyuridine 5′-monophosphate analogue inhibits human immunodeficiency virus infection Molecular Pharmacology. 41: 441-445. PMID 1372082  0.68
1992 Singh B, Arlinghaus RB. The mos proto-oncogene product: Its role in oocyte maturation, metaphase arrest, and neoplastic transformation Molecular Carcinogenesis. 6: 182-189. PMID 1332729 DOI: 10.1002/Mc.2940060303  0.68
1992 Bai W, Singh B, Yang Y, Arlinghaus RB. Evidence for interaction between v-Mos and a p34cdc2 isoform, p35cdk Oncogene. 7: 1757-1763. PMID 1323818  0.68
1992 Sastry KJ, Nehete PN, Venkatnarayanan S, Morkowski J, Platsoucas CD, Arlinghaus RB. Rapid in vivo induction of HIV-specific cd8+ cytotoxic T lymphocytes by a 15-amino acid unmodified free peptide from the immunodominant V3-loop of GP120 Virology. 188: 502-509. PMID 1316670 DOI: 10.1016/0042-6822(92)90504-I  0.68
1992 Konings DA, Nash MA, Maizel JV, Arlinghaus RB. Novel GACG-hairpin pair motif in the 5' untranslated region of type C retroviruses related to murine leukemia virus. Journal of Virology. 66: 632-40. PMID 1309906 DOI: 10.1128/Jvi.66.2.632-640.1992  0.68
1992 Singh B, Stocking C, Walker R, Yang YD, Ostertag W, Arlinghaus RB. v-mos proteins encoded by myeloproliferative sarcoma virus and its ts159 mutant. Journal of Virology. 66: 1267-72. PMID 1309903 DOI: 10.1128/Jvi.66.2.1267-1272.1992  0.68
1991 Campbell ML, Arlinghaus RB. Current status of the BCR gene and its involvement with human leukemia Advances in Cancer Research. 57: 227-256. PMID 1950704 DOI: 10.1016/S0065-230X(08)61000-3  0.68
1991 Bai W, Singh B, Karshin WL, Shonk RA, Arlinghaus RB. Phosphorylation of v-mos Ser 47 by the mitotic form of p34cdc2 Oncogene. 6: 1715-1723. PMID 1833715  0.68
1991 Zhao X, Singh B, Arlinghaus RB. Inhibition of c-mos protein kinase blocks mouse zygotes at the pronuclei stage Oncogene. 6: 1423-1426. PMID 1832216  0.68
1991 Sastry KJ, Arlinghaus RB. Identification of T-cell epitopes without B-cell activity in the first and second conserved regions of the HIV Env protein Aids. 5: 699-707. PMID 1715718 DOI: 10.1097/00002030-199106000-00009  0.68
1991 Weber M, Kubiak JZ, Arlinghaus RB, Pines J, Maro B. c-mos proto-oncogene product is partly degraded after release from meiotic arrest and persists during interphase in mouse zygotes Developmental Biology. 148: 393-397. PMID 1657664 DOI: 10.1016/0012-1606(91)90347-6  0.68
1990 Sastry KJ, Arlinghaus RB. A novel HIV vaccine strategy Hematologic Pathology. 4: 157-159. PMID 2258362  0.68
1990 Zhao X, Batten B, Singh B, Arlinghaus RB. Requirement of the c-mos protein kinase for murine meiotic maturation Oncogene. 5: 1727-1730. PMID 2176285  0.68
1990 Singh B, Al-Bagdadi F, Liu J, Arlinghaus RB. Use of antipeptide antibodies to probe the catalytic activity of p37v-mos Virology. 178: 535-542. PMID 2171192 DOI: 10.1016/0042-6822(90)90351-Q  0.68
1990 Al-Bagdadi F, Singh B, Arlinghaus RB. Evidence for involvement of the protein kinase C pathway in the activation of p37v-mos protein kinase Oncogene. 5: 1251-1257. PMID 2168030  0.68
1990 Herzog NK, Nash M, Ramagli LS, Arlinghaus RB. v-mos protein produced by in vitro translation has protein kinase activity Journal of Virology. 64: 3093-3096. PMID 2159564 DOI: 10.1128/Jvi.64.6.3093-3096.1990  0.68
1990 Hamelin R, Honore N, Sergiescu D, Singh B, Gerfaux J, Arlinghaus RB. Reversion of thermosensitive splicing defect of moloney murine sarcoma virus ts110 by oversplicing of viral RNA Journal of Virology. 64: 1378-1382. PMID 2154617 DOI: 10.1128/Jvi.64.3.1378-1382.1990  0.68
1990 Campbell ML, Li W, Arlinghaus RB. P210 BCR-ABL is complexed to P160 BCR and ph-P53 proteins in K562 cells Oncogene. 5: 773-776. PMID 2140598  0.68
1990 Roy LM, Singh B, Gautier J, Arlinghaus RB, Nordeen SK, Maller JL. The cyclin B2 component of MPF is a substrate for the c-mosxe proto-oncogene product Cell. 61: 825-831. PMID 2140529 DOI: 10.1016/0092-8674(90)90192-H  0.68
1990 Liu J, Singh B, Wlodek D, Arlinghaus RB. Cell cycle-mediated structural and functional alteration of P85gag-mos protein kinase activity Oncogene. 5: 171-178. PMID 2138725  0.68
1989 Li W, Smith LA, Kabat KG, Kloetzer WS, Arlinghaus RB. Differential effects of tumor promoters on P210(bcr-abl) expression Hematologic Pathology. 3: 113-123. PMID 2687223  0.68
1989 Li W, Dreazen O, Kloetzer W, Gale RP, Arlinghaus RB. Characterization of bcr gene products in hematopoietic cells Oncogene. 4: 127-138. PMID 2648252  0.68
1989 Singh B, Arlinghaus RB. Vimentin phosphorylation by p37mos protein kinase in vitro and generation of a 50-kDa cleavage product in v-mos-transformed cells Virology. 173: 144-156. PMID 2554568 DOI: 10.1016/0042-6822(89)90230-4  0.68
1989 Arlinghaus RB. Vaccines against tumor antigens Advances in Veterinary Science and Comparative Medicine. 33: 377-395. PMID 2539001  0.68
1989 Herzog NK, Ramagli LS, Arlinghaus RB. Somatic cell expression of the c-mos protein Oncogene. 4: 1307-1315. PMID 2530484  0.68
1988 Li W, Kloetzer WS, Arlinghaus RB. A novel 53 kDa protein complexed with P210(bcr-abl) in human chronic myelogenous leukemia cells Oncogene. 2: 559-566. PMID 3133627  0.68
1988 Herzog NK, Singh B, Elder J, Lipkin I, Trauger RJ, Millette CF, Goldman DS, Wolfes H, Cooper GM, Arlinghaus RB. Identification of the protein product of the c-mos proto-oncogene in mouse testes Oncogene. 3: 225-229. PMID 2970613  0.68
1988 Singh B, Wittenberg C, Hannink M, Reed SI, Donoghue DJ, Arlinghaus RB. The histidine-221 to tyrosine substitution in v-mos abolishes its biological function and its protein kinase activity. Virology. 164: 114-20. PMID 2966489 DOI: 10.1016/0042-6822(88)90626-5  0.68
1988 Singh B, Herzog NK, Liu J, Arlinghaus RB. p37(mos) encoded by the HT-1 strain of Moloney murine sarcoma virus has an associated protein kinase activity Oncogene. 3: 79-85.  0.68
1987 Kurzrock R, Kloetzer WS, Talpaz M, Blick M, Walters R, Arlinghaus RB, Gutterman JU. Identification of molecular variants of p210(bcr-abl) in chronic myelogenous leukemia Blood. 70: 233-236. PMID 2885048  0.68
1987 Singh B, Goldman R, Hutton L, Herzog NK, Arlinghaus RB. The P55 protein affected by v-mos expression is vimentin Journal of Virology. 61: 3625-3629. PMID 2822968 DOI: 10.1128/Jvi.61.11.3625-3629.1987  0.68
1986 Steck PA, Gallick GE, Maxwell SA, Moser RP, Gutterman JU, Yung WKA, Kloetzer WS, Arlinghaus RB. Expression of epidermal growth factor receptor and associated glycoprotein on cultured human brain tumor cells Journal of Cellular Biochemistry. 32: 1-10. PMID 3533968 DOI: 10.1002/jcb.240320102  0.68
1986 Kurzrock R, Blick MB, Talpaz M, Velasquez WS, Trujillo JM, Kouttab NM, Kloetzer WS, Arlinghaus RB, Gutterman JU. Rearrangement in the breakpoint cluster region and the clinical course in Philadelphia-negative chronic myelogenous leukemia Annals of Internal Medicine. 105: 673-679. PMID 3094418 DOI: 10.7326/0003-4819-105-5-673  0.68
1986 Escobedo J, Singh B, Dina D, Arlinghaus RB. Temperature-dependent cytocidal effects of Moloney murine sarcoma virus Virus Research. 6: 75-84. PMID 3026112 DOI: 10.1016/0168-1702(86)90058-4  0.68
1986 Singh B, Hannink M, Donoghue DJ, Arlinghaus RB. p37(mos)-Associated serine/threonine protein kinase activity correlates with the cellular transformation function of v-mos Journal of Virology. 60: 1148-1152. PMID 3023666 DOI: 10.1128/Jvi.60.3.1148-1152.1986  0.68
1986 Singh B, Wittenberg C, Reed SI, Arlinghaus RB. Moloney murine sarcoma virus encoded p37mos expressed in yeast has protein kinase activity. Virology. 152: 502-6. PMID 3014729 DOI: 10.1016/0042-6822(86)90156-X  0.68
1986 Hamelin R, Chan EKL, Tan EM, Arlinghaus RB. Antibodies against small nuclear ribonucleoproteins immunoprecipitate complexes containing ts110 moloney murine sarcoma virus genomic and messenger RNAs Virology. 152: 87-99. PMID 3012876 DOI: 10.1016/0042-6822(86)90374-0  0.68
1986 Singh B, Sparrow JT, Hedge AM, Arlinghaus RB. Expression of the v-mos gene alters a Mr 55,000 protein during acute infection by Moloney murine sarcoma virus. Proceedings of the National Academy of Sciences of the United States of America. 83: 3629-33. PMID 3012522  0.68
1986 Hamelin R, Kabat K, Blair D, Arlinghaus RB. Temperature-sensitive splicing defect of ts110 Moloney murine sarcoma virus is virus encoded Journal of Virology. 57: 301-309. PMID 3001353  0.68
1985 Maxwell SA, Arlinghaus RB. Serine kinase activity associated with moloney murine sarcoma virus-124-encoded p37mos Virology. 143: 321-333. PMID 2998008 DOI: 10.1016/0042-6822(85)90119-9  0.68
1985 Maxwell SA, Arlinghaus RB. A cAMP-independent serine/threonine kinase activity is associated with the mos sequences of ts110 Moloney murine sarcoma virus-encoded P85(gag-mos) Journal of General Virology. 66: 2135-2146. PMID 2995551  0.68
1985 Arlinghaus RB. The ts110 Moloney mouse sarcoma virus system: gag-mos gene products and cellular transformation Journal of General Virology. 66: 1845-1853. PMID 2993477  0.68
1985 Maxwell SA, Arlinghaus RB. Use of site-specific antibodies to perturb the serine kinase catalytic activity of p37(mos) Journal of Virology. 55: 874-876. PMID 2991608 DOI: 10.1128/jvi.55.3.874-876.1985  0.68
1985 Gallick GE, Sparrow JT, Singh B, Maxwell SA, Stanker LH, Arlinghaus RB. Recognition of mos-related proteins with an antiserum to a peptide of the v-mos gene product. The Journal of General Virology. 66: 945-55. PMID 2987403 DOI: 10.1099/0022-1317-66-5-945  0.68
1985 Hamelin R, Brizzard BL, Nash MA, Murphy EC, Arlinghaus RB. Temperature-sensitive viral RNA expression in Moloney murine sarcoma virus ts110-infected cells. Journal of Virology. 53: 616-23. PMID 2982039 DOI: 10.1128/Jvi.53.2.616-623.1985  0.68
1985 Maxwell SA, Arlinghaus RB. Further characterization of the in vitro products generated by proteolytic cleavage of Gazdar murine sarcoma virus p65(gag) Journal of General Virology. 66: 97-107. PMID 2981963  0.68
1984 Lai CN, Gallick GE, Arlinghaus RB, Becker FF. Temperature‐dependent transmembrane potential changes in cells infected with a temperature‐sensitive moloney sarcoma virus Journal of Cellular Physiology. 121: 139-142. PMID 6480709 DOI: 10.1002/Jcp.1041210117  0.68
1984 Nash M, Brown NV, Wong JL, Arlinghaus RB, Murphy EC. S1 nuclease mapping of viral RNAs from a temperature-sensitive transformation mutant of murine sarcoma virus. Journal of Virology. 50: 478-88. PMID 6323748 DOI: 10.1128/Jvi.50.2.478-488.1984  0.68
1984 Gallick GE, Arlinghaus RB. Incorporation of lipids into variants of Moloney sarcoma virus which produce gag-mos fusion proteins Virology. 133: 228-232. PMID 6322433 DOI: 10.1016/0042-6822(84)90444-6  0.68
1984 Gallick GE, Hamelin R, Maxwell S, Duyka D, Arlinghaus RB. The gag-mos hybrid protein of ts110 moloney murine sarcoma virus: variation of gene expression with temperature Virology. 139: 366-374. PMID 6097031 DOI: 10.1016/0042-6822(84)90382-9  0.68
1984 Kloetzer WS, Maxwell SA, Arlinghaus RB. Further characterization of the P85gag-mos-associated protein kinase activity Virology. 138: 143-155. PMID 6093355 DOI: 10.1016/0042-6822(84)90154-5  0.68
1984 Tumilowicz JJ, Gallick GE, East JL, Pathak S, Trentin JJ, Arlinghaus RB. Presence of retrovirus in the B95-8 Epstein-Barr virus-producing cell line from different sources In Vitro. 20: 486-492. PMID 6086497 DOI: 10.1007/BF02619622  0.68
1983 Murphy EC, Arlinghaus RB. Comparative Tryptic Peptide Analysis of P85gag-mos of Mo-MuSV ts-110 and the P38-P23 mos-Related Products of Wild-Type Virus Progress in Nucleic Acid Research and Molecular Biology. 29: 141-144. PMID 6607485 DOI: 10.1016/S0079-6603(08)60441-9  0.68
1983 Kloetzer WS, Maxwell SA, Arlinghaus RB. P85(gag-mos) encoded by ts110 Moloney murine sarcoma virus has an associated protein kinase activity Proceedings of the National Academy of Sciences of the United States of America. 80: 412-416. PMID 6601272  0.68
1983 Naso RB, Stanker LH, Kopchick JJ, Ng VL, Karshin WL, Arlinghaus RB. Further studies on the glycosylated gag gene products of Rauscher murine leukemia virus: Identification of an N-terminal 45,000-dalton cleavage product Journal of Virology. 45: 1200-1206. PMID 6601196 DOI: 10.1128/Jvi.45.3.1200-1206.1983  0.68
1983 Stanker LH, Gallick GE, Horn JP, Arlinghaus RB. P85gag-mos encoded by ts110 Moloney murine sarcoma virus: rapid at the restrictive temperature. The Journal of General Virology. 64: 2203-11. PMID 6311952 DOI: 10.1099/0022-1317-64-10-2203  0.68
1983 Connor CG, Moore PB, Brady RC, Horn JP, Arlinghaus RB, Dedman JR. The role of calmodulin in cell transformation. Biochemical and Biophysical Research Communications. 112: 647-54. PMID 6303327 DOI: 10.1016/0006-291X(83)91512-7  0.68
1983 Stanker LH, Horn JP, Gallick GE, Kloetzer WS, Murphy EC, Blair DG, Arlinghaus RB. Gag-mos Polyproteins encoded by variants of the Moloney strain of mouse sarcoma virus. Virology. 126: 336-47. PMID 6302990 DOI: 10.1016/0042-6822(83)90483-X  0.68
1983 Stanker LH, Gallick GE, Kloetzer WS, Murphy EC, Arlinghaus RB. P85: A gag-mos polyprotein encoded by ts110 Moloney murine sarcoma virus Journal of Virology. 45: 1183-1189. PMID 6300456 DOI: 10.1128/Jvi.45.3.1183-1189.1983  0.68
1983 Junghans RP, Murphy EC, Arlinghaus RB. Electron microscope analysis of ts110 moloney mouse sarcoma virus, a variant of wild-type virus with two RNAs containing large deletions (PII:0022-2836(82)90150-4) Journal of Molecular Biology. 166: 689.  0.68
1983 Stanker LH, Gallick GE, Horn JP, Arlinghaus RB. P85(gag-mos) encoded by ts110 Moloney murine sarcoma virus: Rapid at the restrictive temperature Journal of General Virology. 64: 2203-2211.  0.68
1982 Ng VL, Wood TG, Arlinghaus RB. Processing of the env gene products of Moloney murine leukaemia virus. The Journal of General Virology. 59: 329-43. PMID 7077302 DOI: 10.1099/0022-1317-59-2-329  0.68
1982 Murphy EC, Arlinghaus RB. Comparative tryptic peptide analysis of candidate P85gag-mos of ts1 10 moloney murine sarcoma virus and P38-P23 mos gene-related proteins of wild-type virus Virology. 121: 372-383. PMID 6981878 DOI: 10.1016/0042-6822(82)90175-1  0.68
1982 Kloetzer WS, Arlinghaus RB. Binding of retrovirus-associated protein kinase and proteins to Staphylococcus aureus Journal of General Virology. 60: 365-370. PMID 6955449  0.68
1982 Junghans RP, Murphy EC, Arlinghaus RB. Electron microscopic analysis of ts110 Moloney mouse sarcoma virus, a variant of wild-type virus with two RNAs containing large deletions Journal of Molecular Biology. 161: 229-250. PMID 6296395 DOI: 10.1016/0022-2836(82)90150-4  0.68
1982 Robberson DL, Thornton GB, Marshall MV, Arlinghaus RB. Novel circular forms of mengovirus-specific double-stranded RNA detected by electron microscopy Virology. 116: 454-467. PMID 6175078 DOI: 10.1016/0042-6822(82)90139-8  0.68
1981 Horn JP, Wood TG, Murphy EC, Blair DG, Arlinghaus RB. A selective temperature-sensitive defect in viral RNA expression in cells infected with a ts transformation mutant of murine sarcoma virus. Cell. 25: 37-46. PMID 7273137 DOI: 10.1016/0092-8674(81)90229-4  0.68
1981 Brown RL, Horn JP, Wible L, Arlinghaus RB, Brinkley BR. Sequence of events in the transformation process in cells infected with a temperature-sensitive transformation mutant of Moloney murine sarcoma virus. Proceedings of the National Academy of Sciences of the United States of America. 78: 5593-7. PMID 6946495  0.68
1981 Kopchick JJ, Harless J, Geisser BS, Killam R, Hewitt RR, Arlinghaus RB. Endodeoxyribonuclease activity associated with Rauscher murine leukemia virus Journal of Virology. 37: 274-283. PMID 6260982 DOI: 10.1128/Jvi.37.1.274-283.1981  0.68
1981 Maxwell S, Arlinghaus RB. In vitro proteolytic cleavage of Gazdar murine sarcoma virus p65gag Journal of Virology. 39: 963-967. PMID 6169847  0.68
1981 Thornton GB, Robberson DL, Arlinghaus RB. Attachment of avidin-coupled spheres to linear and circular forms of mengovirus double-stranded RNA Journal of Virology. 39: 229-237. PMID 6168770  0.68
1980 Horn JP, Wood TG, Blair DG, Arlinghaus RB. Partial characterization of a moloney murine sarcoma virus 85,000-dalton polypeptide whose expression correlates with the transformed phenotype in cells infected with a temperature-sensitive mutant virus. Virology. 105: 516-25. PMID 7423857  0.68
1980 Murphy EC, Wills N, Arlinghaus RB. Suppression of murine retrovirus polypeptide termination: effect of amber suppressor tRNA on the cell-free translation of Rauscher murine leukemia virus, Moloney murine leukemia virus, and Moloney murine sarcoma virus 124 RNA. Journal of Virology. 34: 464-73. PMID 7373716  0.68
1980 Murphy EC, Arlinghaus RB. Effect of canavanine on murine retrovirus polypeptide formation Journal of Virology. 33: 954-961. PMID 7365878  0.68
1980 Ng VL, Kopchick JJ, Karshin WL, Wood TG, Arlinghaus RB. The structural relatedness of the virus core proteins on Rauscher and Moloney murine leukaemia virus Journal of General Virology. 47: 161-170. PMID 7365462 DOI: 10.1099/0022-1317-47-1-161  0.68
1980 Lyons DD, Murphy EC, Mong SM, Arlinghaus RB. The translation products of Moloney murine sarcoma virus-124 RNA Virology. 105: 60-70. PMID 6251612  0.68
1980 Wood TG, Somers K, Arlinghaus RB. Isolation and partial characterization of a 55,000-dalton protein induced in cells transformed by the ml strain of Moloney murine sarcoma virus. Virology. 105: 148-58. PMID 6251602  0.68
1980 Wood TG, Lyons DD, Ng VL, Murphy EC, Arlinghaus RB. Characterization of viral polyproteins in cells transformed and producing Moloney murine sarcoma virus-124. Biochimica Et Biophysica Acta. 608: 215-31. PMID 6156703 DOI: 10.1016/0005-2787(80)90168-9  0.68
1979 Wood TG, Peltier-Horn J, Robey WG, Blair DG, Arlinghaus RB. Characterization of virus-specified proteins present in NRK cells infected with a temperature-sensitive transformation mutant of Moloney murine sarcoma virus Symposia On Quantitative Biology. 44: 747-757. PMID 6253209  0.68
1979 Kopchick JJ, Karshin WL, Arlinghaus RB. Tryptic peptide analysis of gag and gag-pol gene products of Rauscher murine leukemia virus Journal of Virology. 30: 610-623. PMID 469995  0.68
1979 Murphy EC, Campos D, Arlinghaus RB. Cell-free synthesis of Rauscher murine leukemia virus "gag" and "env" gene products from separate cellular mRNA species Virology. 93: 293-302. PMID 452407 DOI: 10.1016/0042-6822(79)90234-4  0.68
1979 Naso RB, Karshin WL, Wu YH, Arlinghaus RB. Characterization of 40,000- and 25,000-Dalton intermediate precursors to Rauscher murine leukemia virus gag gene products Journal of Virology. 32: 187-198. PMID 94357 DOI: 10.1128/Jvi.32.1.187-198.1979  0.68
1979 Ng VL, Wood TG, Lyons DD, Arlinghaus RB. Characterization of intracellular precursor polyproteins of Moloney murine leukemia virus Journal of Virology. 32: 1051-1056. PMID 92574 DOI: 10.1128/Jvi.32.3.1051-1056.1979  0.68
1979 Wood TG, Arlinghaus RB. Precursor polyproteins of moloney murine leukemia virus Bba Section Nucleic Acids and Protein Synthesis. 565: 183-191. PMID 92341 DOI: 10.1016/0005-2787(79)90094-7  0.68
1978 Murphy EC, Arlinghaus RB. Tryptic peptide analyses of polypeptides generated by premature termination of cell free protein synthesis allow a determination of the Rauscher leukemia virus gag gene order Journal of Virology. 28: 929-935. PMID 731799  0.68
1978 Jamjoom GA, Ng VL, Arlinghaus RB. Inhibition of maturation of Rauscher leukemia virus by amino acid analogs Journal of Virology. 25: 408-412. PMID 621781  0.68
1978 Vizard DL, Ansevin AT, Thornton GB, Mandel M, Arlinghaus RB. Saltatory thermal denaturation of double-stranded viral RNAs Bba Section Nucleic Acids and Protein Synthesis. 519: 138-148. PMID 208611 DOI: 10.1016/0005-2787(78)90068-0  0.68
1978 Murphy EC, Arlinghaus RB. Cell-free synthesis of rauscher murine leukemia virus "gag" and "gag-pol" precursor polyproteins from virion 35 S RNA in a mRNA-dependent translation system derived from mouse tissue culture cells Virology. 86: 329-343. PMID 78568 DOI: 10.1016/0042-6822(78)90074-0  0.68
1978 Kopchick JJ, Jamjoom GA, Watson KF, Arlinghaus RB. Biosynthesis of reverse transcriptase from Rauscher murine leukemia virus by synthesis and cleavage of a gag-pol read-through viral precursor polyprotein Proceedings of the National Academy of Sciences of the United States of America. 75: 2016-2020. PMID 77022  0.68
1978 Murphy EC, Kopchick JJ, Watson KF, Arlinghaus RB. Cell-free synthesis of a precursor polyprotein containing both gag and pol gene products by Rauscher murine leukemia virus 35S RNA Cell. 13: 359-369. PMID 75071 DOI: 10.1016/0092-8674(78)90204-0  0.68
1977 Karshin WL, Arcement LJ, Naso RB, Arlinghaus RB. Common precursor for Rauscher leukemia virus gp69/71, p15(E), and p12(E) Journal of Virology. 23: 787-798. PMID 894795 DOI: 10.1128/Jvi.23.3.787-798.1977  0.68
1977 Arcement LJ, Karshin WL, Naso RB, Arlinghaus RB. "gag" polyprotein precursors of rauscher murine leukemia virus Virology. 81: 284-297. PMID 70879 DOI: 10.1016/0042-6822(77)90145-3  0.68
1977 Jamjoom GA, Naso RB, Arlinghaus RB. Further characterization of intracellular precursor polyproteins of rauscher leukemia virus Virology. 78: 11-34. PMID 67705 DOI: 10.1016/0042-6822(77)90075-7  0.68
1977 Gerry Robey W, Oskarsson MK, Vande Woude GF, Naso RB, Arlinghaus RB, Haapala DK, Fischinger PJ. Cells transformed by certain strains of moloney sarcoma virus contain murine p60 Cell. 10: 79-89. PMID 65230 DOI: 10.1016/0092-8674(77)90142-8  0.68
1976 Arcement LJ, Karshin WL, Naso RB, Jamjoom G, Arlinghaus RB. Biosynthesis of Rauscher leukemia viral proteins: presence of p30 and envelope p15 sequences in precursor polypeptides Virology. 69: 763-774. PMID 1258368 DOI: 10.1016/0042-6822(76)90502-X  0.68
1976 Jamjoom GA, Naso RB, Arlinghaus RB. Selective decrease in the rate of cleavage of an intracellular precursor to Rauscher leukemia virus p30 by treatment of infected cells with actinomycin D Journal of Virology. 19: 1054-1072. PMID 1085824  0.68
1976 Naso RB, Arcement LJ, Karshin WL, Jamjoom GA, Arlinghaus RB. A fucose deficient glycoprotein precursor to Rauscher leukemia virus gp69/71 Proceedings of the National Academy of Sciences of the United States of America. 73: 2326-2330. PMID 1065881 DOI: 10.1073/pnas.73.7.2326  0.68
1976 Marshall MV, Arlinghaus RB. Polyadenylic acid in the genomic RNA of mengovirus Journal of Virology. 19: 743-745. PMID 183022  0.68
1975 Jamjoom G, Karshin WL, Naso RB, Arcement LJ, Arlinghaus RB. Proteins of Rauscher murine leukemia virus: Resolution of a 70,000-dalton, nonglycosylated polypeptide containing p30 peptide sequences Virology. 68: 135-145. PMID 1189292 DOI: 10.1016/0042-6822(75)90155-5  0.68
1975 Naso RB, Arcement LJ, Wood G, Saunders TE, Arlinghaus RB. The cell-free translation of Rauscher leukemia virus RNA into high molecular weight polypeptides. Biochimica Et Biophysica Acta. 383: 195-206. PMID 1120164 DOI: 10.1016/0005-2787(75)90261-0  0.68
1975 Loesch WT, Arlinghaus RB. Stable polypeptides associated with the 250S mengovirus-induced RNA polymerase structure Archives of Virology. 47: 201-215. PMID 164160 DOI: 10.1007/BF01317808  0.68
1974 Loesch WT, Arlinghaus RB. Polypeptides associated with the 250 S mengovirus induced RNA polymerase structure Arch.Ges.Virusforsch.. 46: 253-268. PMID 4375446  0.68
1974 Tsai S, Arlinghaus RB. Formation of mengovirus-like particles in cell-free extracts from virus-infected cells Biochemical and Biophysical Research Communications. 57: 733-739. PMID 4363940 DOI: 10.1016/0006-291X(74)90607-X  0.68
1974 Loesch WT, Arlinghaus RB. Polypeptides associated with the 250 S mengovirus-induced RNA polymerase structure Archiv FüR Die Gesamte Virusforschung. 46: 253-268. DOI: 10.1007/BF01240068  0.68
1961 Ogle JD, Arlinghaus RB, Logan MA. Studies on peptides obtained from enzymic digests of collagen with evidence for the presence of an unidentified compound in this protein Archives of Biochemistry and Biophysics. 94: 85-93. PMID 13730445 DOI: 10.1016/0003-9861(61)90014-5  0.68
Show low-probability matches.